Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone

Journal of Pharmacology and Experimental Therapeutics

Volumn 330, Issue 1, 2009, Pages 13-22

  Nonaka, Yuko ^a,b   Koumura, Akihiro ^a,b   Hyakkoku, Kana ^a   Shimazawa, Masamitsu ^a   Yoshimura, Shinichi ^b   Iwama, Toru ^b   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAZOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; HYPEROXIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; NORMOBARIC HYPEROXIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; BRAIN ISCHEMIA; COMBINED MODALITY THERAPY; HYPEROXIA; MALE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; TETRAZOLES;

EID: 67649861869     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.151548     Document Type: Article

References (36)

1. Capellier G, Maupoil V, Boussat S, Laurent E, and Neidhardt A (1999) Oxygen toxicity and tolerance. Minerva Anestesiol 65:388-392.
2. Chapman TM and Goa KL (2003) Cilostazol: a review of its use in intermittent claudication. Am J Cardiovasc Drugs 3:117-138. (Pubitemid 36665531)
3. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, and Kemp BE (1999) AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285-289. (Pubitemid 29080812)
4. Choi JM, Shin HK, Kim KY, Lee JH, and Hong KW (2002) Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther 300:787-793. (Pubitemid 34164980)
5. Grabowski M, Brundin P, and Johansson BB (1993) Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats. Stroke 24:889-895. (Pubitemid 23163564)
6. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu- Sasamata M, Yuan J, and Moskowitz MA (1997) Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci U S A 94:2007-2012. (Pubitemid 27113952)
7. Hara H, Huang PL, Panahian N, Fishman MC, and Moskowitz MA (1996) Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab 16:605-611. (Pubitemid 26227069)
8. Hashimoto A, Miyakoda G, Hirose Y, and Mori T (2006) Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 189:350-357. (Pubitemid 44634499)
9. Hua Q, Zhu X, Li P, Tang H, Cai D, Xu Y, Jia X, Chen J, and Shen Y (2008) Refined Qing Kai Ling, traditional Chinese medicinal preparation, reduces ischemic stroke-induced infarct size and neurological deficits and increases expression of endothelial nitric oxide synthase. Biol Pharm Bull 31:633-637.
10. Huang Y, Cheng Y, Wu J, Li Y, Xu E, Hong Z, Li Z, Zhang W, Ding M, Gao X, et al. (2008) Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol 7:494-499.
11. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, and Moskowitz MA (1996) Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab 16:981-987. (Pubitemid 26292066)
12. Iizuka H, Sakatani K, and Young W (1990) Neural damage in the rat thalamus after cortical infarcts. Stroke 21:790-794. (Pubitemid 20180805)
13. Jenkinson SG (1993) Oxygen toxicity. New Horiz 1:504-511.
14. Jones BJ and Roberts DJ (1968) The quantitative measurement of motor incoordination in naive mice using an accelerating Rotorod. J Pharm Pharmacol 20:302-304.
15. Kim HY, Singhal AB, and Lo EH (2005) Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol 57:571-575. (Pubitemid 40471171)
16. Kim KY, Shin HK, Choi JM, and Hong KW (2002) Inhibition of lipopolysaccharideinduced apoptosis by cilostazol in human umbilical vein endothelial cells. J Pharmacol Exp Ther 300:709-715.
17. Kimura Y, Tani T, Kanbe T, and Watanabe K (1985) Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 35:1144-1149. (Pubitemid 15030828)
18. Kohda N, Tani T, Nakayama S, Adachi T, Marukawa K, Ito R, Ishida K, Matsumoto Y, and Kimura Y (1999) Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. Thromb Res 96:261-268.
19. Kotani Y, Nakajima Y, Hasegawa T, Satoh M, Nagase H, Shimazawa M, Yoshimura S, Iwama T, and Hara H (2008) Propofol exerts greater neuroprotection with disodium edetate than without it. J Cereb Blood Flow Metab 28:354-366. (Pubitemid 351161289)
20. Lee JH, Kim KY, Lee YK, Park SY, Kim CD, Lee WS, Rhim BY, and Hong KW (2004) Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats. J Pharmacol Exp Ther 308:896-903. (Pubitemid 38263963)
21. Lee JH, Lee YK, Ishikawa M, Koga K, Fukunaga M, Miyakoda G, Mori T, Hosokawa T, and Hong KW (2003) Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats-an MRI study. Brain Res 994:91-98. (Pubitemid 37452441)
22. Lee JH, Park SY, Shin HK, Kim CD, Lee WS, and Hong KW (2007) Poly(ADP-ribose) polymerase inhibition by cilostazol is implicated in the neuroprotective effect against focal cerebral ischemic infarct in rat. Brain Res 1152:182-190. (Pubitemid 46802504)
23. Lee JH, Park SY, Shin HK, Kim CD, Lee WS, and Hong KW (2008) Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury. CNS Neurosci Ther 14:143-152. (Pubitemid 351713318)
24. Lo EH, Hara H, Rogowska J, Trocha M, Pierce AR, Huang PL, Fishman MC, Wolf GL, and Moskowitz MA (1996) Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke 27:1381-1385. (Pubitemid 26286172)
25. Murphy S (2000) Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 29:1-13. (Pubitemid 30031129)
26. Narkowicz CK, Vial JH, and McCartney PW (1993) Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun 19:71-80. (Pubitemid 23310629)
27. Park SY, Lee JH, Kim CD, Lee WS, Park WS, Han J, Kwak YG, Kim KY, and Hong KW (2006) Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation. J Pharmacol Exp Ther 317: 1238-1245. (Pubitemid 43764129)
28. Rogers DC, Campbell CA, Stretton JL, and Mackay KB (1997) Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 28:2060-2065; discussion 2066. (Pubitemid 27459019)
29. Shin HK, Dunn AK, Jones PB, Boas DA, Lo EH, Moskowitz MA, and Ayata C (2007) Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain 130:1631-1642. (Pubitemid 47355921)
30. Singhal AB, Dijkhuizen RM, Rosen BR, and Lo EH (2002a) Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology 58:945-952. (Pubitemid 34242073)
31. Singhal AB, Wang X, Sumii T, Mori T, and Lo EH (2002b) Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 22:861-868. (Pubitemid 34747603)
32. Takei K, Tokuyama K, Kato M, and Morikawa A (1998) Role of cyclic adenosine monophosphate in reducing superoxide anion generation in guinea pig alveolar macrophages. Pharmacology 57:1-7. (Pubitemid 28288862)
33. Tanaka K, Gotoh F, Fukuuchi Y, Amano T, Uematsu D, Kawamura J, Yamawaki T, Itoh N, Obara K, and Muramatsu K (1989) Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia. Stroke 20:668-673. (Pubitemid 19139099)
34. Wakida K, Morimoto N, Shimazawa M, Hozumi I, Nagase H, Inuzuka T, and Hara H (2006) Cilostazol reduces ischemic brain damage partly by inducing metallothionein- 1 and -2. Brain Res 1116:187-193. (Pubitemid 44485011)
35. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, and Kamii H (1994) Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25:165-170. (Pubitemid 24977199)
36. Zhang ZG, Chopp M, Zaloga C, Pollock JS, and Förstermann U (1993) Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke 24:2016-2021; discussion 2021-2022. (Pubitemid 23352737)